Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
Sasaki H, Hayakawa J, Terai Y, Kanemura M, Tanabe-Kimura A, Kamegai H, Seino-Noda H, Ezoe S, Matsumura I, Kanakura Y, Sakata M, Tasaka K, Ohmichi M.
Sasaki H, et al. Among authors: kanakura y.
Oncogene. 2008 Apr 24;27(19):2737-45. doi: 10.1038/sj.onc.1210926. Epub 2008 Jan 14.
Oncogene. 2008.
PMID: 18193094